TAILIEUCHUNG - Hidden Consequences: The costs of industrial water pollution on people, planet and profit

The Minamata poisoning episode provided local researchers with the hard evidence that first linked mercury discharges to its bioaccumulation in the environment. Cats in Minamata were the first to show signs of mercury poisoning, although at the time the unusual behaviour exhibited by the cats was unexplained. The disease was known locally as “dancing cat disease” in reference to the uncontrollable muscle spasms and tremors seen in the poisoned cats. Further research on the cats led scientists to the conclusion that mercury contamination in the fish and shellfish was the cause of this strange and lethal disease. Unfortunately for the people of Minamata, government officials waited. | Hidden Consequences The costs of industrial water pollution on people planet and profit age A hidden pipe only visible at low tide discharges water from a textile factory into canals only 1 km from the Chao Phraya river in Bangkok Thailand. Contents Executive Summary 5 For more information contact enquiries@ Section 1 Rescuing our iconic rivers Thailand. The Chao Phraya River Jy ÌRussia. The Neva River Case Study Case Stud Case Study Case Study The Philippines. The Marilao River System China. The Yangtze River Section 2 Learning from our past mistakes The Swiss Toxic Dumps Case Study Case Study Case Study PCB contamination of the Hudson River in the US Polluted sediments in the Dutch Delta Cost analysis of efforts to clean up sediments contaminated with hazardous chemicals Case Study 9 10 14 22 30 38 42 Acknowledgements We would like to thank the following people who contributed to the creation of this report and the accompanying Policy Q A. If we have forgotten anyone they know that that our gratitude is also extended to them Orana Chandrasiri Madeleine Cobbing Tommy Crawford Peter Donath Steve Erwood Martin Forter Ken Geiser Elaine Hill Martin Hojsik Gao Jing Daniel Kessler Daniel Kramb Alexey Kiselev Aldert van der Kooij Veronica Lee Cameron McColgan John Novis Ply Pirom Rick Reibstein Melissa Shinn Ilze Smit Mary Taylor Chemko Strazske s persistent PCBs in the Laborec River in Slovakia Beverly Thorpe Diana Guio Torres 50 Katerina Ventusová Munung Wang Yixiu Wu Matthias Wuthrich Designed by Section 3 A Toxic-Free Future - Providing a blueprint towards zero discharge of hazardous chemicals Greenpeace demands Arc Communications 59 66 JN 361 Footnotes 68 Published by Greenpeace International Ottho Heldringstraat 5 1066 AZ Amsterdam The Netherlands Note to the reader Throughout this report we refer to the terms Global North and Global South to describe two distinct groups of countries. The term Global South is used to describe developing

• Môi trường
• Epidemiology
• Sexually Transmitted
• Infections Among
• Military Environment
• Syphilis
• Herpes Simplex Virus
• Reproductive epidemiology
• Modern epidemiology
• Nutritional epidemiology
• Environmental epidemiology
• Clinical epidemiology
• Veterinary epidemiology
• The development
• Veterinary medicine
• The scope of epidemiology
• Describing disease occurrence
• Comparative epidemiology
• Maintenance of infection
• Cancer epidemiology
• Molecular classification
• Genetic epidemiology
• Causal inference
• Cancer incidence
• Molecular epidemiology
• Late blight
• Review on molecular epidemiology
• Molecular epidemiology in relation
• Devastating late blight pathogen
• Fractures in dogs
• Clinical epidemiology of fractures in dogs
• Clinical epidemiology of fractures
• Showing fractures in dogs
• Lecture Introduction to Epidemiology
• Introduction to Epidemiology
• Infectious disease epidemiology
• Disease prevention and control
• Disease screening
• Epidemics investigation
• public health
• healthcare
• epidemiology principles
• analytic epidemiology
• Health Practice
• Principles of Epidemiology
• Ecologic studies
• Social epidemiology
• Using secondary data
• Improve study accuracy
• C ausal diagrams
• Design strategies
• Questionnaire in clinical epidemiology
• Survey sheet for medica
• Medical survey layout
• Medical questionnaire development
• Epidemiology of Dermatomycoses
• Infections Observed
• Humans and Animals
• Great Concern
• MRSA Epidemiology
• Emphasis on MLST
• Epidemiology in gynecological diseases
• Gynecological diseases
• Basic epidemiology
• Models of causation
• Environmental factors
• Childhood Obesity
• Epidemiology and Risk Factors
• Epidemiological
• Clinical Aspects
• Developing Country
• Early Infant
• Medical device regulation
• Medical device epidemiology
• Active surveillance
• Necessary conditions
• Medical device nomenclature
• Data sources
• effective surveillance
• Epidemiology Cluster
• Data Analysis
• Biology Cluster
• Carcinogenesis Cluster
• Prevention Cluster
• Descriptive Studies
• Disease Registers
• Cohort Studies
• Intervention Trials
• Epidemiological FieldWork
• Epidemiological Studies
• Population Based Studies
• Risk Factors
• Hepatocellular Carcinoma
• Surgical Treatment
• Liver Metastases
• Evidence based medicine
• Systematic reviews
• Health economics
• Health improvement
• Demonstrating association
• Observational studies
• Design considerations
• Clinical trials
• Statistical modeling
• Mathematical modeling
• Clinical gastroenterology
• The changing epidemiology of IBD
• The pathogenesis
• The mesalamine based therapies
• The adult patient
• Journal of Science and Technology
• Complex environment representation in epidemiology ABM
• Application on H5N1 propagation
• Individual based epidemiological model
• Climate change
• Climate change and epidemiology
• Human parasitosis in Egypt
• Future of such parasitic diseases
• Scenarios for climate change
• Ovine brucellosis
• Caprine brucellosis
• Serodiagnosis and epidemiology
• Brucellosis in sheep
• Goats and its serodiagnosis
• Infectious bursal disease
• Broiler chickens
• Broiler chickens in Haryana
• Retrospective study on epidemiology
• IBD outbreaks
• BMC Pediatrics
• Rotavirus causing diarrhea
• Children hospitals
• Enzyme Linked Immunosorbent Assay
• Decision making
• Lay epidemiology
• Risk evaluation
• Patient provider communication
• Vaccine safety concerns
• Heterologous immunity